TRENTON, N.J. (AP) — In a story Nov. 8 about a new drug approval, The Associated Press misspelled the drug’s name. It is Prevymis, not Prevymix.
A corrected version of the story is below:
FDA OKs drug to block infection after marrow transplant
U.S. regulators approve new drug ...
WASHINGTON (AP) — A unanimous Supreme Court is speeding up the time for generic biotech drugs to become available to the public in a ruling that means a loss of billions in sales to the makers of original versions.
The justices ruled Monday in favor of generic drug maker Sandoz in its ...
WASHINGTON (AP) — A conservative doctor-turned-pundit with deep ties to Wall Street and the pharmaceutical industry is President Donald Trump’s pick to lead the Food and Drug Administration.
Dr. Scott Gottlieb would be tasked with Trump’s goal of cutting red tape at the FDA, which ...
House OKs bill bolstering medical research, drug approvals
WASHINGTON (AP) — The House easily approved a sweeping biomedical bill Wednesday that would help drug and medical device companies win swifter government approval of their products, boost disease research and drug-abuse spending and revamp federal mental health programs.
The compromise, ...
GOP prepares for House vote on medical research bill
WASHINGTON (AP) — Republicans and Democrats put finishing touches Tuesday on a $6.3 billion medical research bill as GOP leaders prepared to try pushing the measure through the lame-duck Congress by next week. The White House said it backs the measure, all but ensuring its approval.
- BusinessWireGlobal Retinal Vein Occlusion Treatment Market 2019-2023| Strong Pipeline and Recent Drug Approvals to Boost Demand | TechnavioOctober 26, 2018
- BusinessWireUTILITY Receives Investigational New Drug Approval from US FDASeptember 19, 2018
- BusinessWireCertara Software or Services Supported 95% of the US FDA Novel Drug Approvals in First Half of 2018August 8, 2018
- BusinessWireUnited States Medical Marijuana Market Forecast 2018-2022: Medical Cannabis Revenue will Overtake Recreational in the Next 4 Years - ResearchAndMarkets.comAugust 8, 2018